Search research articles
Contact Us
Filters
Showing results (1-10 of 29) with videos related to
Page
of 3
Sort By:
Journal of Biopharmaceutical Statistics
|
July 23, 2024
Up-front matching: an ongoing recruitment method for prospective observational studies that mimics randomization for selected baseline covariates
William H Olson, Ibrahim Turkoz
Bipolar Disorders
|
January 18, 2006
Topiramate monotherapy in the management of acute mania: results of four double-blind placebo-controlled trials
Stuart F Kushner, Akbar Khan, Rosanne Lane, et al.
The Journal of Clinical Psychiatry
|
November 13, 2012
Cost and cost-effectiveness in a randomized trial of long-acting risperidone for schizophrenia
Larry Alphs, William H Olson, Ibrahim Turkoz, et al.
The Journal of Dermatological Treatment
|
November 13, 2015
Characterizing patients with psoriasis on injectable biologics adalimumab, etanercept, and ustekinumab: A chart review study
Mingliang Zhang, Amir Goren, Seina Lee, et al.
The Annals of Pharmacotherapy
|
April 24, 2003
Topiramate titration to response: analysis of individualized therapy study (TRAITS)
W Edwin Dodson, Marc Kamin, Lesley Kraut, et al.
The Annals of Pharmacotherapy
|
February 11, 2005
Effect of cotherapy reduction on tolerability of epilepsy add-on therapy: a randomized controlled trial
Dean K Naritoku, Joseph F Hulihan, Lesley Kraut Schwarzman, et al.
Journal of Medical Economics
|
August 28, 2014
Healthcare costs for Crohn's disease patients treated with infliximab: a propensity weighted comparison of the effects of treatment adherence
Brian G Feagan, Chris M Kozma, Terra L Slaton, et al.
Journal of Comparative Effectiveness Research
|
November 19, 2013
Bayesian data analysis in observational comparative effectiveness research: rationale and examples
William H Olson, Concetta Crivera, Yi-Wen Ma, et al.
Journal of Medical Economics
|
March 29, 2014
Inflammatory bowel disease: healthcare costs for patients who are adherent or non-adherent with infliximab therapy
George J Wan, Chris M Kozma, Terra L Slaton, et al.
Journal of Drugs in Dermatology : JDD
|
March 17, 2017
Patient Preference for Dosing Frequency Based on Prior Biologic Experience
Mingliang Zhang, Chureen Carter, William H Olson, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 29) with videos related to
Sort By:
Page
of 3
Journal of Biopharmaceutical Statistics
|
July 23, 2024
Up-front matching: an ongoing recruitment method for prospective observational studies that mimics randomization for selected baseline covariates
William H Olson, Ibrahim Turkoz
Bipolar Disorders
|
January 18, 2006
Topiramate monotherapy in the management of acute mania: results of four double-blind placebo-controlled trials
Stuart F Kushner, Akbar Khan, Rosanne Lane, et al.
The Journal of Clinical Psychiatry
|
November 13, 2012
Cost and cost-effectiveness in a randomized trial of long-acting risperidone for schizophrenia
Larry Alphs, William H Olson, Ibrahim Turkoz, et al.
The Journal of Dermatological Treatment
|
November 13, 2015
Characterizing patients with psoriasis on injectable biologics adalimumab, etanercept, and ustekinumab: A chart review study
Mingliang Zhang, Amir Goren, Seina Lee, et al.
The Annals of Pharmacotherapy
|
April 24, 2003
Topiramate titration to response: analysis of individualized therapy study (TRAITS)
W Edwin Dodson, Marc Kamin, Lesley Kraut, et al.
The Annals of Pharmacotherapy
|
February 11, 2005
Effect of cotherapy reduction on tolerability of epilepsy add-on therapy: a randomized controlled trial
Dean K Naritoku, Joseph F Hulihan, Lesley Kraut Schwarzman, et al.
Journal of Medical Economics
|
August 28, 2014
Healthcare costs for Crohn's disease patients treated with infliximab: a propensity weighted comparison of the effects of treatment adherence
Brian G Feagan, Chris M Kozma, Terra L Slaton, et al.
Journal of Comparative Effectiveness Research
|
November 19, 2013
Bayesian data analysis in observational comparative effectiveness research: rationale and examples
William H Olson, Concetta Crivera, Yi-Wen Ma, et al.
Journal of Medical Economics
|
March 29, 2014
Inflammatory bowel disease: healthcare costs for patients who are adherent or non-adherent with infliximab therapy
George J Wan, Chris M Kozma, Terra L Slaton, et al.
Journal of Drugs in Dermatology : JDD
|
March 17, 2017
Patient Preference for Dosing Frequency Based on Prior Biologic Experience
Mingliang Zhang, Chureen Carter, William H Olson, et al.
Page
of 3